Reimbursement Subcommittee


The Reimbursement Subcommittee strives to:

  • Educate the cell therapy industry on pre-commercialization reimbursement considerations.
  • Identify and recruit leaders in industry who have late-stage development products and have addressed regulatory and manufacturing hurdles.

Projects and Objectives

  • Describe reimbursement policies on a regional basis to include the UK, Australia and USA.
  • Organize an ISCT webinar on reimbursement considerations.


Committee Chair


Dawn Driscoll, PhD, MBA
DCi Biotech
Perth, Australia


Committee Members

Rui Bento, PharmD, MSc
Porto Salvo, Portugal

Panos Kefalas, PhD, MBA
Cell and Gene Therapy Catapult
London, United Kingdom

Richard Maziarz, MD
Oregon Health and Science Universtiy
Portland, OR, United States

Francesco Paolucci, PhD
Murdoch University
Perth, Australia

Eric Strati, PharmD
New York, NY, United States


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.